Relationship between intracellular traffic of proteins containing expanded polyglutamine, aggregate formation, and cell death

含有扩展聚谷氨酰胺的蛋白质的细胞内运输、聚集体形成和细胞死亡之间的关系

基本信息

项目摘要

In order to elucidate the mechanism of selective neuronal cell death in polyglutamine diseases caused by abnormal expansion of CAG repeat units, various constructs expressing part of ataxin-3, the product of the disease-causing gene MJD 1 of Machado-Joseph disease, as fusion protein with GFP, were introduced to COS cells, and subcellular localization of expressed ataxin-3 fragments was analyzed under fluorescence microscopy.We found that the C-terminal end of ataxin-3 is essential to formation of cytoplasmic aggregates. These cytoplasmic aggregates were surrounding the nucleus and formed mostly in the juxtanuclear region. Confocal laser microscopy revealed that these aggregates were co-localized with tubulin, and especially, juxtanuclear aggregates were co-localized with gamma-tubulin, which is now known as a marker of microtubulus organizing center (MTOC). These results indicate that the C-terminal portion of ataxin-3 can interact with tubulins, and the aggregates formed by expanded polyglutamine and the C-terminal region, accumulate in the MTOCs.The N-terminal region flanking the polyglutamine tract of ataxin-3 contained active sequence of nuclear localization signal and also a region with coiled-coil conformation. The latter region was found to be invloved in the aggregates formed by expanded polyglutamine. Overexpression of the construct expressing the latter region resulted in the reduction of intranuclear aggregates formed by expanded polyglutamine derived from DRPLA protein and subsequent cell death.Our present study indicates the important role of intramolecular domains of the products of disease-causig genes in the formation of cytoplasmic and intranuclear aggregates.
为了阐明CAG重复单元异常扩增引起的多聚谷氨酰胺疾病中选择性神经元细胞死亡的机制,将Machado-Joseph病致病基因MJD - 1的产物ataxin-3部分表达的不同构建体作为GFP融合蛋白引入COS细胞,在荧光显微镜下分析表达的ataxin-3片段的亚细胞定位。我们发现ataxin-3的c末端对细胞质聚集体的形成至关重要。这些细胞质聚集体围绕着细胞核,主要形成于核旁区。激光共聚焦显微镜显示,这些聚集体与微管蛋白共定位,特别是近核聚集体与γ -微管蛋白共定位,γ -微管蛋白是微管组织中心(MTOC)的标志。这些结果表明,ataxin-3的c端部分可以与微管蛋白相互作用,并且由扩展的聚谷氨酰胺和c端区域形成的聚集体在mtoc中积累。在ataxin-3聚谷氨酰胺通道两侧的n端区域含有核定位信号的活性序列,也有一个螺旋状构象区域。后一区域被发现参与膨胀聚谷氨酰胺形成的聚集体。表达后一区域的构建体的过表达导致由DRPLA蛋白衍生的聚谷氨酰胺形成的核内聚集体减少和随后的细胞死亡。我们目前的研究表明致病基因产物的分子内结构域在细胞质和核内聚集体形成中的重要作用。

项目成果

期刊论文数量(17)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takiyama Y: "Single sperm analysis of the CAG repents in the gene for dentatorubral-pallidoluysian atrophy (DRPLA):the instability of the CAG repeats in the DRPLA gene is prominent among the CAG repeat disenses." Hum Mol Genet. (in press). (1999)
Takiyama Y:“对齿状红核-苍白球路易体萎缩 (DRPLA) 基因中 CAG 重复序列的单精子分析:DRPLA 基因中 CAG 重复序列的不稳定性在 CAG 重复疾病中最为突出。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takiyama Y, Sakoe K, Amaike M, Soutome M, Ogawa T, Nakano I, Nishizawa M: "Single sperm analysis of the CAG repeats in the gene for dentatorubral-pallidoluysian atrophy (DRPLA): the instability of the CAG repeats in the DRPLA gene is prominent among the C
Takiyama Y、Sakoe K、Amaike M、Soutome M、Okawa T、Nakano I、Nishizawa M:“齿状红核苍白球萎缩症 (DRPLA) 基因中 CAG 重复的单精子分析:DRPLA 中 CAG 重复的不稳定性
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takiyama Y et al: "A Japanese family with spinocerebellar ataxia type 6 which includes three individuals homezygous for an expanded CAG repeat in the SCA6/CACNL1A4 gene"J Neurol. Sci. 158. 141-147 (1998)
Takiyama Y 等人:“一个患有 6 型脊髓小脑共济失调的日本家族,其中包括三个 SCA6/CACNL1A4 基因中扩展的 CAG 重复同源的个体”J Neurol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takiyama.Y,et al: "Maternal anticipation in Machado-Joseph disease(MJD):some familial factors independent of the number of CAG repeat units may play a role in genetic anticipation in a Japanese MJD family." J Neurol Sci. 155. 141-145 (1998)
Takiyama.Y 等人:“马查多-约瑟夫病 (MJD) 中的母亲预期:一些与 CAG 重复单位数量无关的家族因素可能在日本 MJD 家族的遗传预期中发挥作用。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takiyama Y, et al: "A Japanese family with spinocerebellar ataxia type 6 which includes three individuals homozygous for an expanded GAG repeat in the SCA6/CACN1A4 gene"J. Neurol Sci. 158. 141-147 (1998)
Takiyama Y 等人:“一个患有 6 型脊髓小脑共济失调的日本家族,其中包括三个 SCA6/CACN1A4 基因中扩展的 GAG 重复纯合子个体”J.
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NISHIZAWA Masatoyo其他文献

NISHIZAWA Masatoyo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NISHIZAWA Masatoyo', 18)}}的其他基金

Molecular pathogenesis of ALS: approach from TDP-43 function.
ALS 的分子发病机制:从 TDP-43 功能出发的方法。
  • 批准号:
    22249036
  • 财政年份:
    2010
  • 资助金额:
    $ 7.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Analysis of the qene for Machado-Joseph disease
马查多-约瑟夫病的基因分析
  • 批准号:
    05454261
  • 财政年份:
    1993
  • 资助金额:
    $ 7.74万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Establishment of cerebellar Purkinje cell lines by somatic cell fusion
通过体细胞融合建立小脑浦肯野细胞系
  • 批准号:
    03670422
  • 财政年份:
    1991
  • 资助金额:
    $ 7.74万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Analysis of pathogenetic mechanism of Alzheimer's disease using trisomy 16 chimera mice
16三体嵌合体小鼠分析阿尔茨海默病发病机制
  • 批准号:
    63570375
  • 财政年份:
    1988
  • 资助金额:
    $ 7.74万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Brain-targeted delivery of therapeutic molecules by exosomes derived from engineered human iPS cells: a potential therapeutic approach for Huntington's disease
通过源自工程化人类 iPS 细胞的外泌体向大脑靶向递送治疗分子:亨廷顿病的潜在治疗方法
  • 批准号:
    10588392
  • 财政年份:
    2023
  • 资助金额:
    $ 7.74万
  • 项目类别:
Nanoscopic Membrane Modulations Induced by Nanoscale Oligomers
纳米级低聚物诱导的纳米膜调节
  • 批准号:
    10790511
  • 财政年份:
    2023
  • 资助金额:
    $ 7.74万
  • 项目类别:
Project 3: Therapeutic Gene Editing for Huntington's Disease
项目3:亨廷顿病的治疗性基因编辑
  • 批准号:
    10668769
  • 财政年份:
    2023
  • 资助金额:
    $ 7.74万
  • 项目类别:
Characterization of small molecules that lower mutant huntingtin protein as potential therapeutics for Huntington’s disease
降低突变亨廷顿蛋白作为亨廷顿病潜在疗法的小分子的表征
  • 批准号:
    10759097
  • 财政年份:
    2023
  • 资助金额:
    $ 7.74万
  • 项目类别:
Investigation on Ataxin2 and Matrin3 in neurodegenerative disease
Ataxin2 和 Matrin3 在神经退行性疾病中的研究
  • 批准号:
    10668022
  • 财政年份:
    2023
  • 资助金额:
    $ 7.74万
  • 项目类别:
The roles of Huntingtin Associated Protein 40 in Huntingtin functions and Huntingtons disease pathogenesis
亨廷顿相关蛋白 40 在亨廷顿功能和亨廷顿病发病机制中的作用
  • 批准号:
    10741626
  • 财政年份:
    2023
  • 资助金额:
    $ 7.74万
  • 项目类别:
Mechanistic Basis for Non-Canonical Translation in Neurological Disease
神经系统疾病非规范翻译的机制基础
  • 批准号:
    10591832
  • 财政年份:
    2023
  • 资助金额:
    $ 7.74万
  • 项目类别:
Determinants of HIV-1 innate immune sensing and its role in shaping the lymphoid environment.
HIV-1 先天免疫感应的决定因素及其在塑造淋巴环境中的作用。
  • 批准号:
    10712594
  • 财政年份:
    2023
  • 资助金额:
    $ 7.74万
  • 项目类别:
Molecular Origins of Neurodegeneration through Force Detangling of Toxic RNA
通过强制解开有毒 RNA 导致神经退行性变的分子起源
  • 批准号:
    10667873
  • 财政年份:
    2023
  • 资助金额:
    $ 7.74万
  • 项目类别:
Identifying New Astrocytic Kir4.1 Channel Modulators for Treating Huntington's Disease
鉴定用于治疗亨廷顿病的新型星形细胞 Kir4.1 通道调节剂
  • 批准号:
    10681097
  • 财政年份:
    2023
  • 资助金额:
    $ 7.74万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了